← FDA Drug Approvals (Drugs@FDA)

BRIVARACETAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2022-12-20

Drug application

FDA Application #

ANDA214918

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIVARACETAM

Generic name

Brivaracetam

Active ingredients

BRIVARACETAM

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

LUPIN

First approval

2022-12-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown